Clinical Trial Update: Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis [Phase 3]

View source ↗

Summary

A Phase 3 trial compares low-dose melphalan with dexamethasone to high-dose melphalan with autologous stem cell transplant in primary systemic amyloidosis; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Amyloidosis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Melphalan (Melphalan)

Snippet

Sponsor: Mayo Clinic | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 3 | Status: COMPLETED | Results posted: 2015-07-21